Yang Z, Chen W, Liu Y, Niu Y
Infect Agent Cancer. 2025; 20(1):7.
PMID: 39915786
PMC: 11800463.
DOI: 10.1186/s13027-024-00630-2.
Biswas D, Liu Y, Herrero J, Wu Y, Moore D, Karasaki T
Nat Cancer. 2025; 6(1):86-101.
PMID: 39789179
PMC: 11779643.
DOI: 10.1038/s43018-024-00883-1.
Hashimoto A, Hashimoto S
Cancers (Basel). 2024; 16(23).
PMID: 39682280
PMC: 11640101.
DOI: 10.3390/cancers16234094.
Ishikawa Y, Fukue H, Iwakami R, Ikeda M, Iemura K, Tanaka K
Cancer Sci. 2024; 116(2):420-431.
PMID: 39604214
PMC: 11786318.
DOI: 10.1111/cas.16406.
Hintzen D, Schubert M, Soto M, Medema R, Raaijmakers J
EMBO Rep. 2024; 25(11):5169-5193.
PMID: 39294502
PMC: 11549362.
DOI: 10.1038/s44319-024-00252-0.
Resolving tumor evolution: a phylogenetic approach.
Li L, Xie W, Zhan L, Wen S, Luo X, Xu S
J Natl Cancer Cent. 2024; 4(2):97-106.
PMID: 39282584
PMC: 11390690.
DOI: 10.1016/j.jncc.2024.03.001.
DNA damage response-related ncRNAs as regulators of therapy resistance in cancer.
Gao Z, Luan X, Wang X, Han T, Li X, Li Z
Front Pharmacol. 2024; 15:1390300.
PMID: 39253383
PMC: 11381396.
DOI: 10.3389/fphar.2024.1390300.
Chromosomal instability: a key driver in glioma pathogenesis and progression.
Mazzoleni A, Awuah W, Sanker V, Bharadwaj H, Aderinto N, Tan J
Eur J Med Res. 2024; 29(1):451.
PMID: 39227895
PMC: 11373396.
DOI: 10.1186/s40001-024-02043-8.
Micronuclear collapse from oxidative damage.
Di Bona M, Chen Y, Agustinus A, Mazzagatti A, Duran M, Deyell M
Science. 2024; 385(6712):eadj8691.
PMID: 39208110
PMC: 11610459.
DOI: 10.1126/science.adj8691.
Cancer, metastasis, and the epigenome.
Kiri S, Ryba T
Mol Cancer. 2024; 23(1):154.
PMID: 39095874
PMC: 11295362.
DOI: 10.1186/s12943-024-02069-w.
Polyploid giant cancer cells: origin, possible pathways of formation, characteristics, and mechanisms of regulation.
Liu P, Wang L, Yu H
Front Cell Dev Biol. 2024; 12:1410637.
PMID: 39055650
PMC: 11269155.
DOI: 10.3389/fcell.2024.1410637.
The link between gluten intake and the risk of cancers.
Bakhtiari S, Asri N, Maleki S, Rahimi S, Jabbari A, Ahmadzadeh A
Gastroenterol Hepatol Bed Bench. 2024; 17(2):132-139.
PMID: 38994510
PMC: 11234494.
DOI: 10.22037/ghfbb.v17i2.2945.
Clinical and molecular significance of homologous recombination deficiency positive non-small cell lung cancer in Chinese population: An integrated genomic and transcriptional analysis.
Wang Y, Ma Y, He L, Du J, Li X, Jiao P
Chin J Cancer Res. 2024; 36(3):282-297.
PMID: 38988485
PMC: 11230889.
DOI: 10.21147/j.issn.1000-9604.2024.03.05.
Modulatory effects of cancer stem cell-derived extracellular vesicles on the tumor immune microenvironment.
Li X, Zhang C, Yue W, Jiang Y
Front Immunol. 2024; 15:1362120.
PMID: 38962016
PMC: 11219812.
DOI: 10.3389/fimmu.2024.1362120.
Profiling Numerical and Structural Chromosomal Instability in Different Cancer Types.
Zhang X, Kschischo M
Methods Mol Biol. 2024; 2825:345-360.
PMID: 38913320
DOI: 10.1007/978-1-0716-3946-7_20.
PHLDA2 reshapes the immune microenvironment and induces drug resistance in hepatocellular carcinoma.
Feng K, Peng H, Lv Q, Zhang Y
Oncol Res. 2024; 32(6):1063-1078.
PMID: 38827322
PMC: 11136693.
DOI: 10.32604/or.2024.047078.
CINner: modeling and simulation of chromosomal instability in cancer at single-cell resolution.
Dinh K, Vazquez-Garcia I, Chan A, Malhotra R, Weiner A, McPherson A
bioRxiv. 2024; .
PMID: 38617259
PMC: 11014621.
DOI: 10.1101/2024.04.03.587939.
The two sides of chromosomal instability: drivers and brakes in cancer.
Hosea R, Hillary S, Naqvi S, Wu S, Kasim V
Signal Transduct Target Ther. 2024; 9(1):75.
PMID: 38553459
PMC: 10980778.
DOI: 10.1038/s41392-024-01767-7.
BUB1/KIF14 complex promotes anaplastic thyroid carcinoma progression by inducing chromosome instability.
Jin T, Ding L, Chen J, Zou X, Xu T, Xuan Z
J Cell Mol Med. 2024; 28(7):e18182.
PMID: 38498903
PMC: 10948175.
DOI: 10.1111/jcmm.18182.
Aneuploidy Can Be an Evolutionary Diversion on the Path to Adaptation.
Kohanovski I, Pontz M, Vande Zande P, Selmecki A, Dahan O, Pilpel Y
Mol Biol Evol. 2024; 41(3).
PMID: 38427813
PMC: 10951435.
DOI: 10.1093/molbev/msae052.